Validation of an HIV-1 inactivation protocol that is compatible with intracellular drug analysis by mass spectrometry.

MLA

van Kampen, Jeroen J. A., et al. “Validation of an HIV-1 Inactivation Protocol That Is Compatible with Intracellular Drug Analysis by Mass Spectrometry.” Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, vol. 847, no. 1, Feb. 2007, pp. 38–44. EBSCOhost, https://doi.org/10.1016/j.jchromb.2006.10.001.

APA

van Kampen, J. J. A., Verschuren, E. J., Burgers, P. C., Luider, T. M., de Groot, R., Osterhaus, A. D. M. E., & Gruters, R. A. (2007). Validation of an HIV-1 inactivation protocol that is compatible with intracellular drug analysis by mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 847(1), 38–44. https://doi.org/10.1016/j.jchromb.2006.10.001

Chicago

van Kampen, Jeroen J A, Esther J Verschuren, Peter C Burgers, Theo M Luider, Ronald de Groot, Albert D M E Osterhaus, and Rob A Gruters. 2007. “Validation of an HIV-1 Inactivation Protocol That Is Compatible with Intracellular Drug Analysis by Mass Spectrometry.” Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 847 (1): 38–44. doi:10.1016/j.jchromb.2006.10.001.